\
&
Contact us
\
&
Contact us
Published on | 27 minutes ago
ProgrammesEP PerMed has launched a new Stakeholder Forum to foster early collaboration between public research, industry, and other key stakeholders. The Forum provides a networking platform to accelerate the translation of personalised medicine research into clinical practice and commercial applications.
The European Partnership for Personalised Medicine (EP PerMed) has recently launched the EP PerMed Stakeholder Forum, bringing together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine on a single platform to support the translation of research findings into clinical practice and marketable applications.
The Stakeholder Forum aims to offer simple, low-barrier access to initiate new collaborations and jointly advance the implementation of personalised medicine. The platform is intended for the broader personalised medicine community. More information and registration is available here: Home | EP PerMed Stakeholder Forum .
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.
ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.
